Caudal Epidural Steroid and Trigger Point Injection

• Status: Recruiting
• Trial end date: 2024-12-20
• Target enrollment: 0
• Participant gender: All

Summary

This prospective randomized study will be conducted in Bolu Abant İzzet Baysal University Hospital. Chronic low back and hip pain 72 patients aged between 18-70 years will be included in the study. The primary output of our study was NRS scores. The study of Manchikanti. L et al. (control group NRS reduction 4.4 ± 1.8; α margin of error 0.05, power 99%) (3) was taken as the basis for determining the sample size. Using the G Power 3 calculator program, 72 patients were identified to reduce their NRS scores by 25%. With a 20% exclusion rate, the total number of patients was calculated as 90

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Abant Izzet Baysal University
• Treatments: Bupivacaine; Lidocaine; Triamcinolone

Criteria

Inclusion Criteria:

• Low back or leg pain that has been going on for at least 2 months,

• Patients between the ages of 18-70,

• Disc herniation or radiculopathy in lumbar MRI examination .To be mentally competent to understand and evaluate NRS, ODI, and SF-36 forms.

exclusion criteria

• Being pregnant or lactating,

• Presence of spinal canal stenosis,

• The presence of bleeding diathesis,

• Presence of disease with progressive neurological deficit,

• The presence of serious psychiatric illness,

• Presence of progressive neurological deficit or incontinence,

• Having an epidural steroid injection in the last 6 months, Having uncontrolled diabetes mellitus Having hypertension,

• Known history of allergy to local anesthetics or corticosteroids,

• The patient does not want treatment,

• Local infection at the injection site,

• Infections such as discitis, spondylodiscitis, and sacroiliitis.